Home | Recruitment

Complete

Trials by recruitment status

Public Title Date of registrationsort icon Sponsor
Tisuacryl® in Dentistry 2008-09-12 BIOMAT
Tisuacryl® in esophageal surgery 2008-09-12 BIOMAT
Phase Ib-IIb trial of the live oral cholera vaccine 638 in adult volunteers in Mozambique. 2008-09-12 FINLAY
Challenge study to determine the protective efficacy of a single oral dose of the attenuated 638 strain. 2008-09-12 FINLAY
Phase I-II study of live oral cholera vaccine 638 in healthy adult volunteers in Cuba. 2008-09-19 FINLAY
Cutaneous Use of Tisuacryl® 2008-09-30 BIOMAT
THERESA 2008-10-07 CIGB
FarmaPEG-I 2008-10-07 CIGB
Recombinant interferon alpha-2b in paranoid schizophrenia. 2009-02-11 CIGB
Recombinant IFN alpha-2b for relapsing –remitting multiple sclerosis. 2009-02-11 CIGB
Evaluation of the antiinflammatory effect of the Vimang® cream in patients with Dermatitis chronic disease. 2009-02-12 CQF
CITOPROT-III 2009-02-26 CIGB
Effect of the supplementation with Vimang ® on indicators of oxidative stress in young people with Diabetes Mellitus type 1. 2009-02-27 CQF
Extract of Mangifera indica L. (Vimang®)- Third age- Phase II. 2009-02-27 CQF
Safety and immunogenicity of commercial Hepatitis B vaccines. 2009-02-27 CIGB
Extract of Mangifera indica L. (Vimang®)-Ischemic Stroke 2009-03-13 CQF
Evaluation of the neuroprotector effect of an extract of stem bark of Mangifera indica L. (Vimang®) in patient with Spinocerebellar Hereditary Ataxia Type 2 2009-03-13 CQF
Therapeutic Equivalence between ior EPOCIM and EPO without albumin, for patients with Chronic Renal failure on Peritoneal dialysis methods.(Hemodialysis or peritoneal dialysis). 2009-07-03 CIMAB
Impact of Human Recombinant Erithoropoietin (ior EPOCIM) in cancer patients with post Chemo and Radiotherapy induced anemia. 2009-07-03 CIMAB
Impact of Recombinant Human Erythropoietin (ior EPO-CIM) in oncology pediatric patients with post chemo and /or radiotherapy. 2009-07-03 CIMAB